JM Biotech Co., Ltd
- Business Type : Manufacturing
- Year Established : 2012
- Main Markets : Worldwide
- Main Products : Cosmeceutical,Skin Care,Aesthetics,Hair Loss
- Links : Beauty & Personal Care, Skin Care Products, Acne Treatment,
Company Introduction
 JM Biotech Co. is a R&D, manufacturing and overseas sales specialist subsidiary ofJeilMedixPharmaceutical Co. and IKIN Co. Ltd.
JM Biotech Co. was incorporated as an independent business unit in 2013 in order to satisfy the increasing demand for specialist R&D and overseas distribution, in addition to providing cutting-edgecosmeceutical andnutraceuticalproducts as well as the supply of high-quality medical devices (notably the sterile direct dermal injecting devices). In addition, JM Biotech supplies overseas clients with raw materials for solutions, including peptides and growth factors.
Prior to the emergence of JM Biotech Co., since 1999 theJeilMedixgroup has been active in striving for international patents for a variety of high-quality medical instruments and products, whilst maintainingJeilMedixPharmaceutical Co.’s leading edge in the Korean pharmaceutical,nutraceutical,cosmeceuticalandmedi-aesthetic markets. We continue to define our success by our responsiveness to our clients’ specific needs and aspirations rather than certain trends in the market.
With 16 years of experience in the field, recently in 2013 JM Biotech acquired international patents for 5th-generation painlessmicroneedledirect dermal injecting devices under theTurtlePin®andBelluspin®signature series label. In addition, our highly effective peptide and growth factor solutions such asTurtlePin®HL,Belluspin®A50,Belluspin®W30,Belluspin®H40 are at the core of our world-class export product line.
JM Biotech Co. was incorporated as an independent business unit in 2013 in order to satisfy the increasing demand for specialist R&D and overseas distribution, in addition to providing cutting-edgecosmeceutical andnutraceuticalproducts as well as the supply of high-quality medical devices (notably the sterile direct dermal injecting devices). In addition, JM Biotech supplies overseas clients with raw materials for solutions, including peptides and growth factors.
Prior to the emergence of JM Biotech Co., since 1999 theJeilMedixgroup has been active in striving for international patents for a variety of high-quality medical instruments and products, whilst maintainingJeilMedixPharmaceutical Co.’s leading edge in the Korean pharmaceutical,nutraceutical,cosmeceuticalandmedi-aesthetic markets. We continue to define our success by our responsiveness to our clients’ specific needs and aspirations rather than certain trends in the market.
With 16 years of experience in the field, recently in 2013 JM Biotech acquired international patents for 5th-generation painlessmicroneedledirect dermal injecting devices under theTurtlePin®andBelluspin®signature series label. In addition, our highly effective peptide and growth factor solutions such asTurtlePin®HL,Belluspin®A50,Belluspin®W30,Belluspin®H40 are at the core of our world-class export product line.
Contact Information
- Telephone : 82-7082553181
- Address : South Korea
- Website : Visit website
Related Products：JM Biotech Co., Ltd
No advertising and no spamming please
JM Biotech Co., Ltd no reviews currently
No reviews currently, you may post the first one.